FRANCES JAMESON: Open Payments
NPI 1851833248 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 5 payments from 5 companies in 2025. Trend: 2023 $112 · 2024 $199 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| GENZYME CORPORATION | 1 | $122 |
| Grifols USA, LLC | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Exeltis, USA Inc. | 1 | $103 |
Products named: AUSTEDO XR, FABRAZYME, Prolastin-C Liquid, TWIRLA.
Industry payments across TX — which companies pay providers there.
